Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W DAY

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Pediatrics|March 1, 1991
High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell diseaseW C Wang, E H Kovnar, I L Tonkin, et al.
The Journal of Pediatrics|October 1, 1995
Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell diseaseP J Chesney, J A Wilimas, G Presbury, et al.
The New England Journal of Medicine|August 12, 1993
A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell diseaseJ A Wilimas, P M Flynn, S Harris, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Pediatrics|March 1, 1991
High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell diseaseW C Wang, E H Kovnar, I L Tonkin, et al.
The Journal of Pediatrics|October 1, 1995
Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell diseaseP J Chesney, J A Wilimas, G Presbury, et al.
The New England Journal of Medicine|August 12, 1993
A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell diseaseJ A Wilimas, P M Flynn, S Harris, et al.
Pageof 2